Table 3: Demographics and clinical characteristics of study participants.

Characteristics of the 103 Patients
Variable All (N=103) Treatment experienced (n=86) Treatment naïve (n=17) p-value
Demographics
Females/number (%) 82 (80) 71 (87) 11 (13) 0.095
Males /number (%) 21 (20) 15 (71) 6 (29)
Age in years /median (IQR) 39 (33-46) 39.5 (35-46) 36 (31-40) 0.197
Clinical Characteristics
Time on ART in years /median(IQR) 4(2-7)
Time since HIV diagnosis in years /median (IQR) 5 (3-8) 5 (3-8) 2 (1-4) <0.0001
CD4 count/ median(IQR) 468 (269- 658) 491 (294- 662) 292 (4-540) 0.056
Patient Characteristics by Drug Resistance Mutations
Variable All (N=103) HIVDR+
(n=6), 6%
HIVDR- (n=97), 94% p-value
Age in years /median (IQR) 39 (33-46) 45 (32-55) 39 (33.5-45) 0.852
CD4 count cells /mm3/ median (IQR) 468 (269-658) 261 (127-399) 480 (281-661) 0.117
Viral load/ copies/ml / median /(IQR) 37 (20-37) 37 (20-45) 37 (20-37) 0.688
Time on ART in years/ median(IQR) 3 (0.1-5) 4 (1.5-5) 3 (0.05-5. 5) 0.232

ART, antiretroviral therapy; NNRTI, non-nucleotide reverse transcriptase inhibitor; PI, protease inhibitor; IQR, Interquartile range; HIV, Human immunodeficiency virus; CD4,Cluster of differentiation 4, p values* obtained using Pearson chi squared tests, p values** obtained using median tests, HIVDR+, HIV drug resistance mutations; HIVDR- No HIV drug resistance mutations.